Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Consult Clin Psychol. 2008 Dec;76(6):1083–1089. doi: 10.1037/a0012720

Table 2.

Means (and Standard Errors) of all key study variables as a function of condition and time of measurement for the randomized controlled trial: Intention to treat sample (n = 31)

Treatment (n = 15) Waiting list control (n = 16)
Pre Post Pre Post
Primary Outcomes
 GAD CSR 5.73(0.18) 3.18(0.30) 5.69(0.12) 5.32(0.34)
 PSWQ 65.72(2.11) 54.18(2.35) 72.03(0.94) 68.93(1.47)
 DASS-Anxiety 12.53(1.95) 5.52(1.35) 12.25(2.16) 10.50(2.32)
 DASS-Stress 22.93(2.41) 12.85(1.73) 22.00(2.59) 24.93(3.02)
Secondary Outcomes
 BDI 17.53(1.94) 5.77(1.33) 19.69(1.83) 16.52(2.33)
 QOLI 0.83(0.62) 2.00(0.45) 0.27(0.48) .16(0.37)
 # of add. diagnoses 0.93(0.26) 0.51(0.21) 1.06(0.16) 1.20(0.23)
Mechanism of Change
 AAQ 72.87(3.51) 55.07(3.32) 77.19(2.11) 76.25(2.58)
 MAAS 52.45(4.35) 60.91(3.75) 48.97(4.48) 49.04(3.56)

Note. GAD= generalized anxiety disorder, CSR = Clinician’s Severity Rating from the Anxiety Disorders Interview Schedule for DSM-IV, Lifetime Version; PSWQ = Penn State Worry Questionnaire; DASS-Anxiety = Depression and Anxiety Stress Scales- Anxiety subscale; DASS-Stress = Depression and Anxiety Stress Scales- Stress subscale; BDI = Beck Depression Inventory; QOLI = Quality of Life Inventory; AAQ = Acceptance and Action Questionnaire; MAAS = Mindful Attention and Awareness Scale.